Posted inNews Life Sciences Review and Outlook – 2024 March 8, 2024 Click to view PDF This update provides a summary of 2023 highlights for capital markets, M&A activity, royalty financing transactions and clinical… Posted by By Jhon March 9, 2024Posted inNews
Posted inNews Exact Sciences Rings the Nasdaq Stock Market Closing Bell Exact Sciences (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, visits the Nasdaq MarketSite in Times Square. Posted by By Jhon November 3, 2023Posted inNews
Posted inNews Valsartan Market is likely to expand US$ 2.5 Bn at 10.6% CAGR by 2032 -Novartis, Sun Pharmaceutical, Teva, Mylan, Alembic Pharmaceuticals, Lupin, Aurobindo Pharma, Macleods Pharmaceuticals, HETERO, Torrent Pharmaceuticals, Huaren Pharmaceutical, Jubilant Pharma, Amneal Pharmaceuticals, Zhejiang Huahai Pharmaceutical, Square Pharmaceuticals, Unichem Laboratories, LG Life Sciences – LatAm Insurance Review The Latest published a market study on Valsartan Market provides an overview of current market dynamics in the Valsartan space, as well as what our… Posted by By Jhon December 28, 2022Posted inNews